Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics Inc.
WKN: A3DMHJ / Symbol: AVTX / Name: Avalo Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,041 €
2,50 %
Avalo Therapeutics, Inc. (NASDAQ: AVTX) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics, Inc. (NASDAQ: AVTX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $40.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics, Inc. (NASDAQ: AVTX) is now covered by analysts at Wedbush. They set an "outperform" rating and a $18.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics, Inc. (NASDAQ: AVTX) was upgraded by analysts at Wedbush to a "strong-buy" rating.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics, Inc. (NASDAQ: AVTX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics, Inc. (NASDAQ: AVTX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics, Inc. (NASDAQ: AVTX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $36.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics, Inc. (NASDAQ: AVTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics (NASDAQ:AVTX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics (NASDAQ:AVTX) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics (NASDAQ:AVTX) had its price target raised by analysts at HC Wainwright from $15.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics (NASDAQ:AVTX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $40.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Avalo Therapeutics (NASDAQ:AVTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Neueste Beiträge
DA_Davidson in Progress Software diskutieren